The discovery and recognition of CD4 + Foxp3 + T reg cells as a distinct subset of T cells with immunoregulatory function is a major advance in our understanding of the immune system [1] [2] [3] . T reg cells actively maintain immune homeostasis and self-tolerance, and one prominent T reg cell-mediated suppressive mechanism is dependent on contact with APCs 4 . This physical contact promotes the formation of a specialized signaling platform, known as the IS, at the T reg cell-APC interface.
The discovery and recognition of CD4 + Foxp3 + T reg cells as a distinct subset of T cells with immunoregulatory function is a major advance in our understanding of the immune system [1] [2] [3] . T reg cells actively maintain immune homeostasis and self-tolerance, and one prominent T reg cell-mediated suppressive mechanism is dependent on contact with APCs 4 . This physical contact promotes the formation of a specialized signaling platform, known as the IS, at the T reg cell-APC interface.
CTLA-4 is a potent negative regulator of T cell-mediated immune responses through its actions in both T eff and T reg cells. CTLA-4 is highly expressed on T reg cells 3 , and this high expression, as well as the higher affinity of CTLA-4 for its CD80 (B7-1) and CD86 (B7-2) ligands in comparison with CD28 (ref. 5) , is associated with predominant localization of CTLA-4 at the T reg cell IS and, consequently, displacement of CD28 from the IS 6 . However, despite extensive studies of CTLA-4, little is known about the intracellular signaling pathways initiated upon CTLA-4 engagement by its ligands. The SHP-1, SHP-2 and PP2A phosphatases, which are binding partners of CTLA-4 (ref. 7) , may account for the intrinsic inhibitory activity of CTLA-4 in T eff cells, but a recent study had demonstrated that these phosphatases are not recruited to the T reg cell IS together with CTLA-4 (ref. 6 ). Thus, how CTLA-4 exerts its signaling effects at the T reg cell IS remains unknown.
The T reg cell IS is distinguishable from the 'conventional' IS formed between naive or effector T (T eff ) cells and APCs in several respects.
First, although the T cell antigen receptor (TCR) is present in the central supramolecular activation cluster in both types of IS, the costimulatory CD28 receptor is recruited to the T eff cell IS, whereas CTLA-4 is present at the T reg cell IS 6, 8 . Second, PKC-θ is absent from the T reg cell IS and, moreover, in contrast to the case in T eff cells, it negatively regulates the function of T reg cells 4 . Physical association of PKC-θ, mediated by its V3 domain, with the costimulatory CD28 receptor underlies its recruitment to the central supramolecular activation cluster and essential functions in driving the activation, proliferation and differentiation of T eff cells 9 . Hence, the absence of PKC-θ in the T reg cell IS suggests that TCR signaling events in these cells could differ considerably from those of T eff cells. Nevertheless, proximal TCR signaling appears intact in T reg cells, as indicated by the phosphorylation and activation of the TCR-stimulated signaling proteins TCR, Lck 10 , PDK1 (ref. 11), LAT and PLC-γ1 (ref. 12 ), all of which have been implicated in the in vitro suppressive function of T reg cells. Because of these findings and, in particular, the importance of the association between LAT and activated PLC-γ1 (ref. 12) , which is required for the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P 2 ) and generation of diacylglycerol (DAG), the PKCactivating second messenger, we hypothesized that DAG should be produced locally 13 upon formation of ISs in T reg cells and, furthermore, that this would lead to recruitment of a PKC family member other than PKC-θ to the IS and to the activation of such a PKC species. This PKC may, in turn, positively regulate the function of T reg cells.
Here we show that, by analogy with the PKC-θ-CD28 interaction in T eff cells, which promotes their activation and function 9 , the CD28-related receptor CTLA-4, which is highly expressed on T reg cells and is required for their suppressive function 14, 15 , physically recruits another member of the novel PKC (nPKC) subfamily, PKC-η, which localizes at the T reg cell IS after stimulation. This association required phosphorylated serine residues in PKC-η and a conserved, membrane-proximal motif in the cytoplasmic tail of CTLA-4, respectively. Although development of T reg cells and expression of typical T reg cell markers were normal in PKC-η-deficient (Prkch −/− ) T reg cells, these cells displayed a grossly impaired contact-dependent suppressive activity in vitro and in vivo, which was associated with a grossly defective activation of the transcription factors NFAT and NF-κB. Lastly, we show that defective activation of a focal adhesion complex consisting of the kinase PAK and two additional proteins, PAK-interacting exchange factor (PIX) and G protein-coupled receptor kinase-interacting protein 2 (GIT2), which was physically associated with CTLA-4 and PKC-η, was associated with reduced ability of Prkch −/− T reg cells to serially engage APCs; this provides a potential mechanistic basis for the impaired suppressive activity of these cells. Therefore, strategies that interfere with this signaling pathway may be beneficial for inhibiting T reg cell function in cancer and, hence, boosting the immune response against tumors.
RESULTS
Phospho-PKC- interacts with CTLA-4 in the T reg cell IS By analogy to the interaction of PKC-θ with the CTLA-4-related costimulatory receptor CD28, which is critical for the activation of T eff cells 9 , we first tested whether any PKC isoform could physically interact with CTLA-4. Using T hybridoma cells, we found that CTLA-4 coimmunoprecipitated with a higher than normal molecular weight species of PKC-η (Fig. 1a) , but not with any other T cell-expressed PKC isoforms (Supplementary Fig. 1a) . We reasoned that the shift in molecular weight of PKC-η might be due to phosphorylation. Indeed, treatment with alkaline phosphatase partially reversed the shift of the higher-molecular-weight species of PKC-η and resulted in the appearance of a lower-molecular-weight species (Fig. 1b) , which indicated that CTLA-4 interacts predominantly with phosphorylated PKC-η.
We found phosphorylated PKC-η in unstimulated Foxp3 + T reg cells but not in naive T cells (Fig. 1c) , despite the fact that expression of mRNA encoding PKC-η and PKC-η protein was not substantially different between T eff cells and T reg cells (Supplementary Fig. 1b) . Using a T reg cell-APC conjugation system and confocal microscopy, we observed that, relative to PKC-θ, PKC-η preferentially localized in the T reg cell IS, where it partially colocalized with the TCR (Fig. 1d) . We analyzed the relative intensity of the fluorescence signals of enhanced green fluorescent protein (eGFP)-tagged PKC-η or PKC-θ fusion proteins in the T reg cell IS by calculating the intensity ratio in the IS versus the opposite T cell pole. About 15% (3/20) of imaged cells displayed preferential localization of PKC-θ in the IS (ratio ≥ 5), consistent with the observation that a similar percentage of cells in this population were FoxP3 − (by intracellular staining), representing contaminating activated T eff cells in the induced (i)T reg cell culture. Among the remaining cells, the intensity ratios for PKC-η and PKC-θ were 2.84 ± 0.22 and 1.51 ± 0.18 (average ± s.e.m.; P < 0.0001, twosided Student's t-test), respectively (data not shown). Taken together, these results indicate that phosphorylated PKC-η associates with CTLA-4 in T reg cells and, furthermore, that PKC-η preferentially colocalizes with CTLA-4 in the IS.
Development of Foxp3 + T reg cells is independent of PKC- Given the critical role of CTLA-4 in contact-dependent T reg cell suppressive function, which involves depletion of CD80 and CD86 from APCs 14,15 , we next examined the CD4 + Foxp3 + T reg cell population in the lymphoid organs of Prkch −/− mice by intracellular Foxp3 staining. The number and frequency of CD4 + Foxp3 + cells was not significantly altered in the thymi and spleens of Prkch −/− mice compared to Prkch +/+ mice (Fig. 2a,b and Supplementary Fig. 2a ). However, there was a consistent increase in the numbers of CD4 + Foxp3 + T reg cells in peripheral and mesenteric lymph nodes of these mice (Fig. 2c,d) , which suggested that PKC-η is dispensable for in vivo development of CD4 + Foxp3 + T cells. Cells that have been 'licensed' to become Foxp3 + expressed similar levels of typical T reg cell markers, including Foxp3, TCRβ, CTLA-4, CD25, immunomodulatory receptor GITR and CD44 ( Fig. 2e-j) . Thus, PKC-η is dispensable for natural (n)T reg cell development in vivo, and for iT reg cell differentiation in vitro as assessed by expression of typical T reg cell markers (data not shown). Fig. 2k ), a cytokine that can mediate the suppressive activity of T reg cells 17, 18 .
We next considered the possibility that, despite the presence of an apparently normal T reg cell population in Prkch −/− mice, the suppressive activity of these cells may be defective. We first used a conventional in vitro T reg cell suppression assay, which assessed the proliferation of naive T cells cocultured with T reg cells and stimulated with anti-CD3 plus splenic dendritic cells (DCs) as an APC source. The percentage of dividing effector T (T eff ) cells was consistently greater in cultures with Prkch −/− T reg cells compared to T eff cells cocultured with Prkch +/+ T reg cells (Fig. 3a) . The Prkch −/− T reg cells were substantially impaired in their ability to suppress the proliferation of T eff cells even at high T reg /T eff cell ratios, which indicated that PKC-η expression by T reg cells is important for their function.
To determine the importance of PKC-η in T reg cell function in vivo, we used two distinct experimental models, namely, homeostatic T cell population expansion and tumor growth. Transfer of naive CD4 + CD62L + T cells into immunodeficient mice leads to their massive proliferation, a process generally referred to as homeostatic expansion, although it is likely that some of this proliferation is antigen-driven 19 . T reg cells control the population expansion of T eff cells in a lymphopenic environment 20 . We adoptively transferred purified naive CD45.1 + CD4 + T cells, either alone or in the presence of sorted Prkch +/+ or Prkch −/− CD45.2 + CD4 + GFP + T reg cells, into Rag1 −/− mice, and determined T cell numbers 1 week after transfer. In the presence of Prkch +/+ T reg cells, CD45.1 + T eff cell numbers were significantly reduced in all secondary lymphoid organs we examined; in contrast, we observed minimal or no reduction in T eff cell population expansion in the presence of Prkch −/− T reg cells ( Fig. 3b-d) . Similar numbers of Prkch +/+ and Prkch −/− T reg cells were present in these tissues (Supplementary Fig. 2b ).
We next investigated the ability of Prkch −/− T reg cells to inhibit the immune response against a growing tumor. We adoptively transferred splenocytes, depleted of CD25 + T cells, into Rag1 −/− mice as a source of T eff cells in the absence or presence of T reg cells 1 d before inoculation of B16-F10 melanoma cells 14, 21 . Transfer of CD25 + T cell-depleted splenocytes alone resulted in relatively small skin tumors, whereas mice receiving T eff cells together with Prkch +/+ T reg cells developed massive B16 tumors, which reflected inhibition of the T eff cell antitumor response by the cotransferred T reg cells (Fig. 3e) . Cotransfer of Prkch −/− T reg cells resulted in substantially reduced tumor growth, similar to that seen in mice receiving only T eff cells (Fig. 3e) . Taken together, these results indicate that in the absence of PKC-η, the in vivo suppressive function of T reg cells is attenuated, which leads to enhanced homeostatic proliferation and antitumor immunity. Consistent with the importance of PKC-η in T reg cell suppressive functions, Prkch −/− mice exhibit lymphadenopathy, reflected by increased numbers of T cells and B cells, as well as a higher proportion of CD44 hi T cells, characteristic of an activated phenotype 22 . Indeed, Prkch −/− CD44 hi T cells secreted significantly elevated amounts of effector cytokines, including IL-2, IFN-γ, IL-4 and IL-17A (Fig. 4a-d) , upon in vitro stimulation with anti-CD3 plus anti-CD28 monoclonal antibodies (mAbs). Consistent with this hyperactive phenotype, Prkch −/− mice displayed elevated serum titers of IgE (Fig. 4e) and autoantibodies against double-stranded DNA and histone (Fig. 4f,g ) at 8-12 weeks of age, which implies that the immune system is deregulated and hyperactive in the absence of PKC-η.
We also assessed the ability of Prkch +/+ and Prkch −/− T reg cells to inhibit the development of autoimmune colitis in an established T cell transfer model. Although transfer of naive T cells alone into Rag1 −/− recipient mice induced weight loss, indicative of the development of chronic inflammatory bowel disease, cotransfer of either Prkch +/+ or Prkch −/− GFP + T reg cells protected the recipients against weight loss (Supplementary Fig. 3a) and inhibited the population expansion of T eff (CD45.1 + ) cells (Supplementary Fig. 3b) . Thus, despite the in vitro (Fig. 3a) and in vivo (Fig. 3b-e) severe defects in their suppressive function, Prkch −/− T reg cells were still able to protect, albeit perhaps incompletely, recipient mice against the development of colitis. This finding suggests that in this particular disease model, Prkch −/− T reg cells use an alternative, PKCη-independent suppressive mechanism(s), e.g., IL-10-mediated suppression (Fig. 2k) . Furthermore, increased proliferation (or localization) of Prkch −/− T reg cells in the inflammatory bowel environment may compensate for their defective intrinsic suppressive function. Indeed, we found greater numbers of cotransferred Prkch −/− T reg cells relative to Prkch +/+ T reg cells in the secondary lymphoid organs of the recipient mice, and this effect tended to be more pronounced in mesenteric lymph nodes, which drain the site of inflammation ( Supplementary  Fig. 3c ). Together, these findings suggest that PKC-η is not globally required for all forms of T reg cell-induced suppression, and that it is dispensable for T reg cell-mediated inhibition of colitis.
Mapping and importance of CTLA-4-PKC- interaction
The predominant association of phosphorylated PKC-η with CTLA-4 in T reg cells suggested that phosphorylated residues mediate this interaction. To pinpoint potential phosphorylation site(s) in PKC-η required for its interaction with CTLA-4, we created mutant vectors encoding PKC-η with substitutions in six predicted phosphorylation sites, transfected these mutant vectors into JTAg cells, a Jurkat cell derivative that does not express CD28, along with a vector encoding full-length CTLA-4, and immunoprecipitated the transfected CTLA-4 proteins. Upon costimulation with anti-CD3 mAb and CD86-Fc recombinant protein, we found that mutations of amino acids Ser28 and Ser32 in the C2 domain, or Ser317 in the V3 domain of PKC-η abolished the interaction with CTLA-4; as a control, substitution of three other phosphorylation sites (Ser327, Thr656 or Ser675) did not affect this interaction (Fig. 5a) . Thus, phosphorylation of Ser28 and Ser32 or Ser317 in PKC-η is critical for the interaction with CTLA-4.
To determine whether the association between PKC-η and CTLA-4 is required for the suppressive function of T reg cells, we generated bone marrow (BM) chimeric mice by retrovirally reconstituting Prkch −/− FIG BM cells with wild-type PKC-η or a mutant that does not interact with CTLA-4, PKC-η(S28A,S32A). The retroviral vector used coexpressed a nonsignaling rat CD2 (rCD2) to allow isolation of transduced T cells. We sorted transduced T reg cells (rCD2 + GFP + CD45.2 + ) from chimeric mice and assayed them for their ability to suppress the in vivo homeostatic proliferation of cotransferred naive CD45.1 + T cells. Unlike T reg cells expressing wild-type PKC-η, T reg cells reconstituted with PKC-η(S28A,S32A) were incapable of suppressing naive T cell proliferation in the spleens and lymph nodes of adoptively transferred recipients (Fig. 5b-d) .
To map the critical motif in the cytoplasmic tail of CTLA-4 that is required for the interaction with PKC-η, we substituted four conserved tail residues, i.e., a membrane-proximal positively charged motif (K 188 XXKKR 193 , where X is any amino acid other than K or R), a proline-rich motif (Pro205,Pro206,Pro209) and two tyrosine residues (Tyr201 or Tyr218). We found that mutation of the positively charged K 188 XXKKR 193 motif as well as complete deletion of the CTLA-4 cytoplasmic tail (deletion of amino acids 183-223; ∆183-223) greatly reduced the association with PKC-η; in contrast, substitution of the conserved tyrosine residues or the proline-rich motif did not affect the interaction (Fig. 5e) . This membrane-proximal motif is highly conserved throughout evolution from fish to primates (Supplementary Fig. 4a ). Partial truncation of the cytoplasmic tail of CTLA-4 (∆192-223), which left intact nine membrane-proximal residues, including Lys188 and Lys191, resulted in a residual association with PKC-η, which, however, was weaker than that displayed by full-length CTLA-4 ( Supplementary Fig. 4b ). T reg cells expressing CTLA-4 with a similar incomplete truncation of the cytoplasmic tail have been reported to retain suppressive activity 23, 24 . We also found that the interaction between CTLA-4 and PKC-η was not affected by PP2, an inhibitor of Src-family kinases (data not shown), consistent with the lack of effect of Tyr201 or Tyr218 substitutions in CTLA-4 tail on this interaction. Taken together, these results reveal that the CTLA-4-PKC-η interaction is necessary for the suppressive function of T reg cells, thereby implicating PKC-η in a signaling axis linking CTLA-4 to T reg cell-mediated suppression. 25 . However, activation of LFA-1 and its conversion to a high-affinity state, as measured by adhesion to its ligand, ICAM-1, was intact in Prkch −/− T reg cells (Supplementary Fig. 5 ). Prkch +/+ and Prkch −/− T reg cells expressed similar amounts of neuropilin-1, CD39 and CD73 (data not shown); the latter two are cell-surface molecules that have been implicated in T reg cell-mediated suppression through an adenosine-dependent action 28 .
Impaired CD86 depletion by
To elucidate the signaling mechanism potentially responsible for the PKC-η-mediated suppression, we performed a phosphoproteomic analysis of Prkch +/+ versus Prkch −/− T reg cells and found that PAK2 and GIT2, two components of a focal adhesion complex that promotes focal adhesion disassembly and, hence, cellular motility 29, 30 , were substantially hypophosphorylated in Prkch −/− T reg cells ( Supplementary  Fig. 6a) . A complex of these two proteins together with the guanine nucleotide exchange factors αPIX or βPIX has been found to translocate to the T cell IS and to be required for optimal T eff cell activation 31 . Moreover, CTLA-4 immunoprecipitates from anti-CD3-plus anti-CTLA-4-costimulated Prkch +/+ T reg cells contained not only PKC-η but also GIT2, αPIX and PAK (Fig. 6a) . These proteins were also present in PKC-η immunoprecipitates (data not shown). Of note, recruitment of this complex was unique to CTLA-4 costimulation, because the association of the GIT2-αPIX-PAK complex with CTLA-4 was barely above background level when the cells were costimulated with anti-CD3 plus anti-CD28 mAbs (Supplementary Fig. 6b) . Thus, this particular signaling event is not shared between CTLA-4 and CD28. Furthermore, the activating phosphorylation of PAK kinases was severely reduced in Prkch −/− T reg cells (Fig. 6b) , which indicated impaired activation of this complex.
Given the impaired activation of PAK, and because PAK was found to be required for TCR-induced transcriptional activation of NFAT and the CD28 response element (which includes an NF-κB binding site) in Jurkat T cells 31, 32 , we also examined whether Prkch −/− T reg cells display impaired activation of these transcription factors after costimulation with anti-CD3ε plus anti-CTLA-4 mAbs. In these conditions, we observed a severe defect in NFATc1 and NF-κB activation in the Prkch −/− T reg cells (Fig. 6c) .
Because the GIT-PIX-PAK complex promotes cellular motility through focal adhesion disassembly 29, 30 , we investigated whether the defective activation of the GIT2-αPIX-PAK complex in Prkch −/− T reg cells might result in a more stable conjugation of Prkch −/− T reg cells with APCs. We noticed that the efficiency of conjugation between Prkch −/− T reg cells and APCs was significantly higher by comparison to APC conjugates of Prkch +/+ T reg cells (Fig. 6d) T reg cells impaired activation of the GIT2-αPIX-PAK complex leads to defective breaking of T reg cell-APC contacts.
If Prkch −/− T reg cells display impaired dissociation from engaged APCs because of defective activation of the GIT2-αPIX-PAK complex, this defect may be expected to translate into reduced ability of Prkch −/− T reg cells to serially engage new APCs, which, in turn, could result in reduced suppressive activity. This prediction is based on findings that T reg cells can capture CD80 and CD86 from APCs, a process that depletes the ligands required for CD28 costimulation of T eff cells 15 and is thus a potential mechanism of contact-dependent T reg cell-mediated suppression. To address this possibility, we tested the ability of Prkch +/+ versus Prkch −/− T reg cells to deplete CD86 from cocultured CD45.2 + CD11c + APCs as an indirect measure of APC engagement by the T reg cells. Prkch +/+ and Prkch −/− T reg cells were equally capable of depleting CD86 from these APCs (Fig. 6e) . However, upon subsequent addition of a second pool of APCs, distinguished from the first APC population by their CD45.1 expression, Prkch −/− T reg cells had a significant delay in their ability to deplete CD86 from these newly introduced APCs, as indicated by the fact that it took them about fourfold longer (~16 h versus ~4 h) to execute the same level of CD86 depletion as that accomplished by Prkch +/+ T reg cells (Fig. 6e) . This observation supports the notion that the relative inefficiency of Prkch −/− T reg cells in serially engaging new APCs and, hence, in effectively depleting APC-expressed CD86, could account, at least in part, for their reduced suppressive activity. Our findings imply that a T reg cell-intrinsic signaling mechanism dependent on CTLA-4-PKC-η is required in order to manifest the cell-extrinsic suppressive function of CTLA-4 toward T eff cells.
DISCUSSION
We report an interaction of CTLA-4 with PKC-η and preferential IS localization of PKC-η in T reg cells upon their activation. Moreover, PKC-η and its CTLA-4 association were required for the contactdependent suppressive function of T reg cells, albeit not for their development. Although Prkch −/− T reg cells displayed defective suppressive activity in a conventional in vitro suppression assay, and in in vivo homeostatic proliferation and antitumor immunity models, they could still inhibit the development of autoimmune colitis. Our findings provide two potential explanations for these apparently discrepant observations. First, enhanced expansion of Prkch −/− T reg cells in the inflammatory bowel environment, which was particularly noticeable in mesenteric lymph nodes of recipient mice, could compensate for the reduced intrinsic suppressive function of these cells. Second, T reg cells use various mechanisms of suppression, and the relative importance of each mechanism depends on the environment and the context of the immune response. For example, similar to Prkch −/− T reg cells, Ctla4 −/− T reg cells suppress the development of colitis through intact compensatory expression of IL-10 (ref. 33 ), and we found that Prkch −/− T reg cells expressed normal amounts of IL-10. Thus, the CTLA-4-associated PKC-η-dependent suppressive pathway that we describe here may be less relevant in T reg cell suppressive mechanisms that do not depend on T reg cell-APC contact but, rather, on soluble mediators. If our observations of a dispensable role of PKC-η in T reg cell protection against colitis can be extended to other autoimmune disease models, this would suggest that strategies that selectively inhibit PKC-η or its association with CTLA-4 may disable T reg cells from inhibiting antitumor immunity without affecting the ability of these T reg cells to protect against autoimmune diseases, a notion with important potential translational implications. The T reg cell defect revealed by our study may explain the increased cytokine production and higher amounts of serum IgE and autoantibodies in Prkch −/− mice, although intrinsic hyperactivity of the T eff cells in these mice could also contribute to this increase. Nevertheless, it is interesting to note that mice with a T reg cellspecific deletion of Ctla4 display similar increases in cytokine, IgE and autoantibody amounts 14 , which reinforces the notion of a functionally relevant link between CTLA-4 and PKC-η at the level of T reg cell-mediated suppression.
The recruitment of a GIT2-αPIX-PAK complex to CTLA-4 (and PKC-η) upon TCR plus CTLA-4 (but not CD28) costimulation of T reg cells and its impaired activation in Prkch −/− T reg cells suggest a potential mechanism underlying their impaired suppressive activity, based on previous findings that this macromolecular complex is required for the disassembly of focal adhesions in neurons and epithelial cells 29, 30 . Given the reported localization of this complex to the T cell IS and its importance for activation of T cells 31 , it is possible that the TCR-activated GIT2-αPIX-PAK complex destabilizes T cell-APC contacts, thereby promoting conversion of the mature, concentric IS into an unstable IS (i.e., kinapse), which is important for the motility of T cells and their ability to serially engage new APCs 34 . In the context of contact-dependent, T reg cell-mediated suppression, increased stability of T reg cell-APC conjugates and the concomitant reduction in their ability to serially engage new APCs would be translated to impaired overall suppressive activity. Consistent with this notion, we found that Prkch −/− T reg cells form more efficient contacts with APCs in comparison with their Prkch +/+ counterparts and, furthermore, these Prkch −/− T reg cells displayed a reduced ability to deplete CD86 from a second set of added APCs, likely a reflection of impairment in their disengagement from the first set of APCs. When considered at the population level and the relatively long time during which T reg cells have the opportunity to engage APCs, this effect could translate into an overall reduction in depletion of CD86 and, consequently, reduced suppression of T reg cells. Hence, our findings identify a T reg cell-intrinsic signaling mechanism consisting of a CTLA-4-bound PKC-η-GIT2-αPIX-PAK complex, which has a role in promoting the cell-extrinsic suppressive function of T reg cell-expressed CTLA-4 on T eff cells.
The biology of CTLA-4 is complex and its mechanisms of action in T cells are still incompletely understood. This complexity reflects, to a large extent, the fact that CTLA-4 is expressed both in T eff cells where it functions in a cell-autonomous manner in cis to inhibit their activation, and in T reg cells where it operates in a cell-nonautonomous manner in trans to dampen responses of T eff cells 17, 18, 35 . Earlier studies did not distinguish between these functions, but with the conditional deletion of Ctla4 in T reg cells only, it became evident that expression of CTLA-4 by T reg cells is in most (but not all) cases important for their suppressive function through depletion of CD80 and CD86 from APCs 14, 15, 36 .
Ctla4 −/− mice display fatal lymphoproliferative disorder characterized by the systemic infiltration of pathogenic self-reactive T cells 37, 38 . Although Prkch −/− mice displayed moderate lymphadenopathy, increase in memory-activated T cells and cytokine expression, and elevated IgE and autoantibodies at a relatively young age, they lived into adulthood (~1 year) with no gross signs of pathology (data not shown). Several functional disparities could account for these different phenotypes. First, CTLA-4 inhibits thymocyte negative selection 39 , and, as a result, Ctla4 −/− mice harbor autoreactive T cells that cause tissue damage 40 . However, thymic selection is largely intact in the absence of PKC-η 22 , which suggests that the lack of overt autoreactivity and lymphoproliferation in Prkch −/− mice might limit the self-destructive nature of the hyperactive Prkch −/− T eff cells. Second, the inhibitory effect of CTLA-4 is mediated by a combination of non-mutually exclusive mechanisms consisting of T reg cell-intrinsic as well as T eff cell-intrinsic mechanisms, and both mechanisms can cooperate to dampen T eff cell responses. Third, our findings strongly suggest that the intrinsic ability Prkch −/− T reg cells to deplete CD86 from APCs by transendocytosis (which depends on the CTLA-4 extracellular domain) is intact, and that only the newly described signaling function of CTLA-4, i.e., the dissociation of T reg cells from APCs mediated by the PKC-η-GIT2-αPIX-PAK complex (which depends on the CTLA-4 cytoplasmic domain) is impaired. In contrast, T reg cells from germ-line Ctla4 −/− mice or Foxp3-Cre conditional Ctla4 −/− mice lack both of these CTLA-4 functions.
Our findings of altered APC engagement and presumed reduced motility of Prkch −/− T reg cells may be related to the reported ability of CTLA-4 to reverse the TCR stop signal and promote the motility of T eff cells, possibly via LFA-1 activation 41, 42 . In contrast, T reg cells have been found to be resistant to the CTLA-4-induced reversal of the TCR stop signal, which results in longer contact times with APCs 43 , a scenario that would lead to lower overall T reg cell motility and less frequent serial encounters with new APCs. However, we did not observe a defect in LFA-1 expression or activation in Prkch −/− T reg cells; furthermore, although LFA-1 promotes the formation of a stable IS, our findings point to a defect at a later stage, i.e., disassembly of the IS in the Prkch −/− T reg cells.
Clinical use of anti-CTLA-4 heralded a new era of cancer immunotherapy by targeting immunosuppression 44 . In many tumor tissues, infiltrating T reg cells restrict the function of T eff cells and, therefore, inhibiting critical T reg cell signaling molecules that are important for their function could lead to enhanced antitumor responses 45 . Here we showed that phosphorylated PKC-η is recruited to the T reg cell IS and is associated with the cytoplasmic tail of CTLA-4, and demonstrated the critical importance of this association for the contact-dependent suppressive activity of T reg cells. Hence, the CTLA-4-PKC-η axis could represent a key therapeutic target for T reg cell-dependent suppression in controlling cancer.
METHODS
Methods and any associated references are available in the online version of the paper. 
